Related Experiment Video
Updated: Aug 19, 2026

Reconstruct Human Retinoblastoma In Vitro
Published on: October 11, 2022
Role of the retinoblastoma tumor suppressor protein in cellular differentiation
Don X Nguyen1, Dennis J McCance
1Department of Microbiology and Immunology, University of Rochester, 601 Elmwood Avenue, Rochester, NY 14642, USA.
Abstract:
The retinoblastoma protein (pRb105) is a true tumor suppressor as deregulation of the Rb pathway by either mutation of pRb105 itself or other proteins in the pathway, such as p16INK4a, occur in most cancers. This prototypical family member, along with the related p107 and p130, are involved in the control of cell cycle regulation, but pRb105 has also been shown to be involved in tissue development and differentiation. This prospective will discuss the increasing evidence for a role of pRb105 in cellular differentiation and the fact that various cancers, which contain mutant pRb105, or mutations in proteins in the pRb105 pathway, are perhaps a result of deregulation of differentiation.
Insights
The retinoblastoma protein (pRb105) is crucial for cell cycle control and tissue development. Deregulation of the pRb105 pathway, common in cancers, may stem from disrupted cellular differentiation processes.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- The retinoblastoma protein (pRb105) functions as a tumor suppressor.
- The pRb105 pathway, including proteins like p16INK4a, is frequently deregulated in various cancers.
- pRb105, along with p107 and p130, regulates cell cycle progression.
Purpose of the Study:
- To explore the role of pRb105 in cellular differentiation.
- To investigate the link between pRb105 pathway mutations and cancer development.
- To discuss the hypothesis that cancer arises from deregulation of differentiation.
Main Methods:
- Review of existing scientific literature on pRb105 function.
- Analysis of data linking pRb105 pathway mutations to cancer phenotypes.
- Prospective discussion of emerging evidence.
Main Results:
- Growing evidence supports pRb105's involvement in cellular differentiation.
- Mutations in pRb105 or its pathway proteins are prevalent in cancers.
- Disruption of differentiation is increasingly recognized as a factor in tumorigenesis.
Conclusions:
- The retinoblastoma protein (pRb105) plays a significant role in cellular differentiation.
- Cancers with pRb105 pathway alterations may result from a failure in normal differentiation processes.
- Further research is warranted to fully elucidate the connection between pRb105, differentiation, and cancer.
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Negative Regulator Molecules
Cellular Differentiation
A zygote is a...
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

